Dr Rebecca Bayliss
@RBayliss2023
Followers
40
Following
411
Media
3
Statuses
249
As a guest editor for @JoVEJournal, I am organising a collection titled "Advances and techniques in the development of cancer immuno- and viral therapies @emilyanne611 Interested in contributing? Please submit an abstract here:
0
1
5
Congratulations to @alanlparker, Health and Care Research Wales Senior Research Leader, on winning the 2026 Translational Microbiology Prize from @MicrobioSoc. Find out more. #ResearchWalesFaculty
https://t.co/BCR745ihPZ
0
3
11
@UniofNottingham @DrToniHo @CVRinfo @Edel_PLopez @universitelaval @bfrancescol @uff_br @UofT @UWMadison @rfsuny Marjory Stephenson Prize 2026: Professor Mark Buttner — @JohnInnesCentre Outreach and Engagement Prize 2026: @LindsayBbent — @UniOfSurrey Translational Microbiology Prize 2026: @alanlparker — @thewcrc
0
1
6
Check out our new structural work, including a 3.3Å resolution of the whole Ad10 capsid, and a 4.6Å resolution of the fiber shaft. Identification of a novel structural motif and overexpression of key transcripts elucidated in Adenovirus 10
biorxiv.org
Adenoviruses are widely used as vectors for subunit vaccines and oncolytic therapies. Efficient vectors must infect target cells and deliver therapeutic transgenes at high levels. Species D adenovi...
0
5
5
BiTE-secreting T cells rationally combine with PD-1 blockade and vaccine boosting to reshape antitumor immunity in ovarian cancer https://t.co/9wyCHD42xS
#genetherapy #celltherapy
cell.com
Ovarian cancer (OC) patients receive limited benefit from immunotherapy, suggesting a therapeutic need to enhance antitumor immunity. Engineered BiTE-secreting T cells elicit robust antitumor...
1
3
18
The first Cancer Research Wales Brain Tumour Conference is underway today at Sophia Gardens Cricket Ground. We’re honoured to have @JulieMorganLAB join us for the opening address. #BrainTumourConference
0
2
7
Rydym wedi cael diwrnod gwych yng Nghynhadledd Tiwmorau’r Ymennydd Ymchwil Canser Cymru! Drwy ddod â gwyddonwyr, clinigwyr a niwro-lawfeddygon o bob cwr o Gymru ynghyd ac eu cefnogi, byddwn yn darparu llwyfan i ysgogi darganfyddiad a chreadigrwydd. #CynhadleddTiwmoraurYmenydd
0
1
2
📸 We’ve had an amazing day at the Cancer Research Wales Brain Tumour Conference! By bringing together and supporting scientists, clinicians and neurosurgeons from across Wales, we will provide a platform to drive forward discovery and innovation #BrainTumourConference
1
1
2
Well done to all our fantastic Brain Tumour Conference award winners! Llongyfarchiadau i enillwyr y gwobrau gwych yn ein Cynhadledd Tiwmorau’r Ymenydd. #BrainTumourConference | #CynhadleddTiwmorYrYmennydd
0
1
4
Proud to be part of the Cardiff Cancer Research Partnership (CCRP) a collaboration between @VelindreTrust @cardiffuni and @CV_UHB that launched last week. On #WorldCancerResearchDay it is more important than ever to recognise the strength in working together:
0
2
4
We were delighted to join the CPG for Medical Research event at the @SeneddWales, where we met with @PeterFox61 & @MikeHedgesAM. Both were very happy to meet our researchers and hear about the vital work they do to improve cancer outcomes in Wales. 🧬✨ #CancerResearch #Senedd
0
3
6
Yn falch o fod yn rhan o Bartneriaeth Ymchwil Canser Caerdydd (CCRP), cydweithrediad rhwng @VelindreTrust
@cardiffuni a @CV_UHB a lansiwyd yr wythnos diwethaf. Ar #DiwrnodYmchwilCanserYByd, mae'n bwysicach nag erioed cydnabod cryfder cydweithio:
0
1
2
Potential GW4 funded 4 year PhD project for October 2026 start adopting machine learning to develop precision virotherapies - with co-supervisors Yukun Lai, Marieke Pingen, Kerry Wadey and Julian Fischer. Come, make some smart viruses with us! https://t.co/LvZetH8dDK
gw4biomed.ac.uk
Project Code MRCIIAR26Ca Parker Project Type Wet lab Research Theme Infection, Immunity, Antimicrobial Resistance and Repair Project Summary Download Summary The Viral ImmunoTherapies and Advanced...
0
7
8
At #CICON2025 we’re sharing new data on TROCEPT, our tumour-targeted immunotherapy. •Tumour selectivity: Harnesses αvβ6 integrin to deliver >100x more virus to tumours than to the liver •Local immune activation: TROCEPT-01 (ATTR-01) expresses anti-PD-L1 inside tumours, not
accessiontherapeutics.com
Accession Therapeutics is pleased to announce that five abstracts showcasing the company’s TROCEPT cancer immunotherapy platform have been accepted for presentation at three leading international...
0
2
3
If Carlsberg did #PhD students….immense congratulations to DR Emma Swift on absolutely acing your viva and producing an incredible thesis! A huge volume of important work! Many thanks to examiners Stu Nicklin (Uni of Glasgow) and Magda Meissner for examining! Top job, Dr Swift!
2
1
11
If your still interested in submitting an abstract, there's still time! As a guest editor for @JoVEJournal, I am organising a collection titled "Advances and techniques in the development of cancer immuno- and viral therapies @emilyanne611 Interested in contributing?
0
0
0
If you’re visiting #Eisteddfodd today, do speak to the awesome @LunedBadder representing @cardiffuni, the @virustinkerer lab & @ResearchWales Wales Applied Virology Unit (WAVU), explaining how we develop “#SmartViruses” to treat #Cancer. You can even make a virus of your own!
0
6
12
A short thread about our new paper just published in Molecular Therapy Oncology. Terrific work from first author @RBayliss2023 👏👏
Delighted to share our latest work, published in @MolTherapy Onc https://t.co/eSYO8BNIO0 We describe the development of a suite of avB6 specific oncolytic adenoviruses expressing potent bi-specific immune cell activators designed to immunologically "heat up" tumours.
0
3
5
Delighted to share our latest work, published in @MolTherapy Onc https://t.co/eSYO8BNIO0 We describe the development of a suite of avB6 specific oncolytic adenoviruses expressing potent bi-specific immune cell activators designed to immunologically "heat up" tumours.
cell.com
Virotherapies can deliver anti-cancer therapeutics directly to tumors. Bayliss and colleagues develop a precision virotherapy expressing bispecific immunotherapies from tumor cells resulting in...
2
4
17
@RBayliss2023 @LunedBadder And of course, thank you to @CR_UK who supported this important work and whose funding helped push our "precision virotherapy" to first in human evaluation in the ATTEST trial of ATTR-01. To learn more about our clinical trial agent see this animation -
0
2
5
Over the moon our research showing the targeted delivery of bispecific immune cell activators to tumour cells induces immune cell activation and tumour cell killing is published @MolTherapy oncology 🥳.
cell.com
Virotherapies can deliver anti-cancer therapeutics directly to tumors. Bayliss and colleagues develop a precision virotherapy expressing bispecific immunotherapies from tumor cells resulting in...
0
1
2